Soteria Biotherapeutics Funding: $42M Raised, Series A
Soteria Biotherapeutics is based in San Francisco. It has raised $42M in total funding. Latest round: Series A.
Soteria Biotherapeutics funding overview
Soteria Biotherapeutics is based in San Francisco. Soteria Biotherapeutics has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2021. The round record for Soteria Biotherapeutics runs through 2021; nothing later has been disclosed. Investors on record include Roche Venture Fund, 5AM Ventures, M Ventures, Novartis Venture Fund, Alexandria Venture Investments, Aglaia BioMedical Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.
Frequently asked about Soteria Biotherapeutics funding
How much has Soteria Biotherapeutics raised?
Soteria Biotherapeutics has raised $42M in total disclosed funding across the rounds on record.
Who has invested in Soteria Biotherapeutics?
Roche Venture Fund, 5AM Ventures, M Ventures, Novartis Venture Fund, Alexandria Venture Investments, Aglaia BioMedical Ventures are named among the investors backing Soteria Biotherapeutics.
What was the latest Soteria Biotherapeutics funding round?
The most recent disclosed round is a Series A, announced in May 2021.
Where is Soteria Biotherapeutics based?
Soteria Biotherapeutics is based in San Francisco.
When did Soteria Biotherapeutics last raise?
The last disclosed Soteria Biotherapeutics round closed in May 2021 at Series A.
Totals shown for Soteria Biotherapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.
